Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dummer

Showing results (281-290 of 328) with videos related to

Pageof 33
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2009
Small molecules and targeted therapies in distant metastatic diseaseP Hersey, L Bastholt, V Chiarion-Sileni, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and interleukin 2 (IL-2) with or without cisplatinU Keilholz, P Martus, C J A Punt, et al.
The Journal of Investigative Dermatology|February 13, 2001
Epidermal H(2)O(2) accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes?K U Schallreuter, J Moore, J M Wood, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2007
Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neckJ Bernier, J Bonner, J B Vermorken, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 29, 2020
Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinionR Dummer, P A Ascierto, N Basset-Seguin, et al.
The British Journal of Dermatology|May 12, 2016
An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxelS Thurneysen, P F Cheng, H W Nagel, et al.
The British Journal of Dermatology|December 2, 2017
Individualized treatment approaches for Langerhans cell histiocytosisE Roider, C Signer, B Fehrenbacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2014
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome)R Dummer, M Duvic, J Scarisbrick, et al.
ESMO Open|December 25, 2021
The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspectiveC Sessa, J Cortes, P Conte, et al.
The British Journal of Dermatology|April 22, 2004
Baseline staging in cutaneous malignant melanomaJ Hafner, M Hess Schmid, W Kempf, et al.
Pageof 33

Showing results (281-290 of 328) with videos related to

Sort By:
Pageof 33
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2009
Small molecules and targeted therapies in distant metastatic diseaseP Hersey, L Bastholt, V Chiarion-Sileni, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and interleukin 2 (IL-2) with or without cisplatinU Keilholz, P Martus, C J A Punt, et al.
The Journal of Investigative Dermatology|February 13, 2001
Epidermal H(2)O(2) accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes?K U Schallreuter, J Moore, J M Wood, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2007
Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neckJ Bernier, J Bonner, J B Vermorken, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 29, 2020
Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinionR Dummer, P A Ascierto, N Basset-Seguin, et al.
The British Journal of Dermatology|May 12, 2016
An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxelS Thurneysen, P F Cheng, H W Nagel, et al.
The British Journal of Dermatology|December 2, 2017
Individualized treatment approaches for Langerhans cell histiocytosisE Roider, C Signer, B Fehrenbacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2014
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome)R Dummer, M Duvic, J Scarisbrick, et al.
ESMO Open|December 25, 2021
The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspectiveC Sessa, J Cortes, P Conte, et al.
The British Journal of Dermatology|April 22, 2004
Baseline staging in cutaneous malignant melanomaJ Hafner, M Hess Schmid, W Kempf, et al.
Pageof 33